DVLT vs. RARE

Last updated Apr 1, 2026

Compare and contrast key facts about Datavault AI Inc (DVLT) and Ultragenyx Pharmaceutical Inc. (RARE).

Performance

DVLT vs. RARE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Datavault AI Inc (DVLT) and Ultragenyx Pharmaceutical Inc. (RARE). The values are adjusted to include any dividend payments, if applicable.

DVLT vs. RARE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
DVLT Datavault AI Inc	-2.00%	-68.19%	-88.31%	-98.92%	-92.24%	-60.73%	-70.98%	-82.16%	-27.23%
RARE Ultragenyx Pharmaceutical Inc.	-8.91%	-45.33%	-12.02%	3.22%	-44.90%	-39.25%	224.12%	-1.77%	-44.06%

Fundamentals

EPS DVLT : -$1.02 RARE : -$5.79
PS Ratio DVLT : 8.48 RARE : 3.09
Total Revenue (TTM) DVLT : $6.17M RARE : $672.72M
Gross Profit (TTM) DVLT : $421.00K RARE : $564.07M
EBITDA (TTM) DVLT : -$60.36M RARE : -$488.57M

Returns By Period

In the year-to-date period, DVLT achieves a -2.00% return, which is significantly higher than RARE's -8.91% return.

DVLT

• 1D: 11.41%
• 1M: -12.73%
• YTD: -2.00%
• 6M: -41.37%
• 1Y: -24.73%
• 3Y*: -86.08%
• 5Y*: -89.33%
• 10Y*: —

RARE

• 1D: 8.55%
• 1M: -10.43%
• YTD: -8.91%
• 6M: -30.35%
• 1Y: -42.14%
• 3Y*: -19.46%
• 5Y*: -28.64%
• 10Y*: -10.90%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

DVLT vs. RARE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DVLT

DVLT Risk / Return Rank: 46
DVLT Sharpe Ratio Rank: 36
DVLT Sortino Ratio Rank: 69
DVLT Omega Ratio Rank: 60
DVLT Calmar Ratio Rank: 31
DVLT Martin Ratio Rank: 33

RARE

RARE Risk / Return Rank: 15
RARE Sharpe Ratio Rank: 16
RARE Sortino Ratio Rank: 21
RARE Omega Ratio Rank: 19
RARE Calmar Ratio Rank: 12
RARE Martin Ratio Rank: 9

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DVLT vs. RARE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Datavault AI Inc (DVLT) and Ultragenyx Pharmaceutical Inc. (RARE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	DVLT	RARE	Difference
Sharpe ratio Return per unit of total volatility	-0.12	-0.59	+0.47
Sortino ratio Return per unit of downside risk	1.56	-0.42	+1.97
Omega ratio Gain probability vs. loss probability	1.16	0.93	+0.23
Calmar ratio Return relative to maximum drawdown	-0.34	-0.81	+0.47
Martin ratio Return relative to average drawdown	-0.55	-1.53	+0.98
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

DVLT vs. RARE - Sharpe Ratio Comparison

The current DVLT Sharpe Ratio is -0.12, which is higher than the RARE Sharpe Ratio of -0.59. The chart below compares the historical Sharpe Ratios of DVLT and RARE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	DVLT	RARE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.12	-0.59	+0.47
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.47	-0.53	+0.07
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.20	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.51	-0.10	-0.41

Correlation

The correlation between DVLT and RARE is 0.12, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

DVLT vs. RARE - Dividend Comparison

Neither DVLT nor RARE has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

DVLT vs. RARE - Drawdown Comparison

The maximum DVLT drawdown since its inception was -100.00%, which is greater than RARE's maximum drawdown of -89.57%. Use the drawdown chart below to compare losses from any high point for DVLT and RARE.

Drawdown Indicators

	DVLT	RARE	Difference
Max Drawdown Largest peak-to-trough decline	-100.00%	-89.57%	-10.43%
Max Drawdown (1Y) Largest decline over 1 year	-84.90%	-55.36%	-29.54%
Max Drawdown (5Y) Largest decline over 5 years	-100.00%	-84.01%	-15.99%
Max Drawdown (10Y) Largest decline over 10 years	—	-89.57%	—
Current Drawdown Current decline from peak	-100.00%	-88.19%	-11.81%
Average Drawdown Average peak-to-trough decline	-90.29%	-54.28%	-36.01%
Ulcer Index Depth and duration of drawdowns from previous peaks	52.56%	29.21%	+23.35%

Volatility

DVLT vs. RARE - Volatility Comparison

Datavault AI Inc (DVLT) has a higher volatility of 36.69% compared to Ultragenyx Pharmaceutical Inc. (RARE) at 18.67%. This indicates that DVLT's price experiences larger fluctuations and is considered to be riskier than RARE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	DVLT	RARE	Difference
Volatility (1M) Calculated over the trailing 1-month period	36.69%	18.67%	+18.02%
Volatility (6M) Calculated over the trailing 6-month period	146.63%	67.87%	+78.76%
Volatility (1Y) Calculated over the trailing 1-year period	204.69%	71.96%	+132.73%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	192.35%	54.11%	+138.24%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	167.53%	55.61%	+111.92%

Financials